These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 36924839)

  • 21. SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.
    Lacek KA; Rambo-Martin BL; Batra D; Zheng XY; Hassell N; Sakaguchi H; Peacock T; Groves N; Keller M; Wilson MM; Sheth M; Davis ML; Borroughs M; Gerhart J; Shepard SS; Cook PW; Lee J; Wentworth DE; Barnes JR; Kondor R; Paden CR
    Emerg Infect Dis; 2022 Jul; 28(7):1442-1445. PubMed ID: 35551714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
    Gliga S; Lübke N; Killer A; Gruell H; Walker A; Dilthey AT; Thielen A; Lohr C; Flaßhove C; Krieg S; Pereira JV; Seraphin TP; Zaufel A; Däumer M; Orth HM; Feldt T; Bode JG; Klein F; Timm J; Luedde T; Jensen BO
    Clin Infect Dis; 2023 Feb; 76(3):408-415. PubMed ID: 36189631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Short Series of Case Reports of COVID-19 in Immunocompromised Patients.
    Mishra M; Zahra A; Chauhan LV; Thakkar R; Ng J; Joshi S; Spitzer ED; Marcos LA; Lipkin WI; Mishra N
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
    Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
    Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
    Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing.
    Kim KW; Deveson IW; Pang CNI; Yeang M; Naing Z; Adikari T; Hammond JM; Stevanovski I; Beukers AG; Verich A; Yin S; McFarlane D; Wilkins MR; Stelzer-Braid S; Bull RA; Craig ME; van Hal SJ; Rawlinson WD
    Sci Rep; 2021 Feb; 11(1):3934. PubMed ID: 33594223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant.
    Quintero AM; Eisner M; Sayegh R; Wright T; Ramilo O; Leber AL; Wang H; Mejias A
    Emerg Infect Dis; 2022 Nov; 28(11):2270-2280. PubMed ID: 36285986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
    Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
    Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
    Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
    Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report.
    Baker SJC; Nfonsam LE; Leto D; Rutherford C; Smieja M; McArthur AG
    Virol J; 2024 Jan; 21(1):8. PubMed ID: 38178158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
    Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
    J Infect Dis; 2022 Apr; 225(7):1118-1123. PubMed ID: 34940844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.
    Ko KKK; Yingtaweesittikul H; Tan TT; Wijaya L; Cao DY; Goh SS; Abdul Rahman NB; Chan KXL; Tay HM; Sim JHC; Chan KS; Oon LLE; Nagarajan N; Suphavilai C
    Microbiol Spectr; 2022 Jun; 10(3):e0079122. PubMed ID: 35543562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection.
    El Moussaoui M; Bontems S; Meex C; Hayette MP; Lejeune M; Hong SL; Dellicour S; Moutschen M; Cambisano N; Renotte N; Bours V; Darcis G; Artesi M; Durkin K
    Virus Evol; 2024; 10(1):veae073. PubMed ID: 39399151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion.
    Andrés C; González-Sánchez A; Jiménez M; Márquez-Algaba E; Piñana M; Fernández-Naval C; Esperalba J; Saubi N; Quer J; Rando-Segura A; Miarons M; Codina MG; Ruiz-Camps I; Pumarola T; Abrisqueta P; Antón A
    Clin Microbiol Infect; 2023 Feb; 29(2):240-246. PubMed ID: 36067943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
    Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
    BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis.
    Ordaya EE; Vergidis P; Razonable RR; Yao JD; Beam E
    J Clin Virol; 2023 Mar; 160():105382. PubMed ID: 36731147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report.
    Abroi A; Gerst Talas U; Pauskar M; Shablinskaja A; Reisberg T; Niglas H; Päll T; Nelis M; Tagen I; Soodla P; Lutsar I; Huik K
    Int J Infect Dis; 2022 Nov; 124():41-44. PubMed ID: 36075374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs.
    Goud VR; Chakraborty R; Chakraborty A; Lavudi K; Patnaik S; Sharma S; Patnaik S
    Comput Biol Med; 2022 Jun; 145():105436. PubMed ID: 35366472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of SARS-COV-2 and other respiratory pathogens among a Jordanian subpopulation during Delta-to-Omicron transition: Winter 2021/2022.
    Khasawneh AI; Himsawi NM; Abu-Raideh JA; Sammour A; Abu Safieh H; Obeidat A; Azab M; Tarifi AA; Al Khawaldeh A; Al-Momani H; Al Shboul S; Saleh T
    PLoS One; 2023; 18(3):e0283804. PubMed ID: 36996148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.